1-3 of 3
Enrique Santana, RN
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Erlotinib for Treatment of Myelodysplastic Syndromes: A Phase II Clinical Study

Rami S. Komrokji, MD, Jeffrey E. Lancet, MD, Daohai Yu, Ph.D, Enrique Santana, RN, Lulu Yan, MS, Pamela S Smith, RN, Sara Tinsley, ARNP, Darcie Deaver, ARNP, Ling Zhang, MD, Alan F. List, MD
Journal: Blood
Blood (2010) 116 (21): 1854.
https://doi.org/10.1182/blood.V116.21.1854.1854
Published: 2010
Journal Articles

Correlative Analysis of T Cell Subpopulations and CD20 Expression In a Phase II Study of Lenalidomide In Combination with Rituximab In Patients with Relapsed or Refractory CLL/SLL

Marays Veliz, M.D., John Powers, Ling Zhang, MD, Enrique Santana, RN, Jeffrey E. Lancet, MD, Rami S. Komrokji, MD, Mohamed Kharfan-Dabaja, MD, Sara Tinsley, ARNP, Darcie Deaver, Eduardo M. Sotomayor, MD, Javier Pinilla-Ibarz, MD
Journal: Blood
Blood (2010) 116 (21): 4630.
https://doi.org/10.1182/blood.V116.21.4630.4630
Published: 2010
Journal Articles

A Phase II Study of Gemcitabine, Rituximab, and Oxaliplatin In Combination for Relapsed/Refractory Non-Hodgkin's Lymphomas

Jennifer L. Cultrera, MD, Jijun Liu, MD, Idalia Liboy, MD, Celeste M. Bello, MD, Lubomir Sokol, MD, PhD, Eduardo M. Sotomayor, MD, Enrique Santana, RN, Fernando Cabanillas, MD
Journal: Blood
Blood (2010) 116 (21): 2879.
https://doi.org/10.1182/blood.V116.21.2879.2879
Published: 2010